← Leaderboards
Scott Hammond Medina
Pennsylvania State University, The
$4,370,157
Attributed
$5,150,761
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,150,761 · 4
By mechanism
R01$2,827,764 · 2
R35$1,943,785 · 1
R21$379,212 · 1
Top collaborators
- Girish S Kirimanjeswara2 shared
- Julianna Simon2 shared
- Igor I Slukvin1 shared
Most similar at Pennsylvania State University, The
Same institution · by research overlap
- Julianna Simon$2,880,894
- Anthony D Baughn$5,912,485
- Luke H Herbertson$66,188
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsTechnologyPropertyUptakePeptidesDesignProteinsStructureMolecularMediatingMetabolicTissuesNovel TherapeuticsStructure-Activity RelationshipLiquid SubstanceBiocompatible MaterialsNanoemulsionIn VivoEngineeringFormulationRouteFluorescenceParticlePublishing
Grant awards (13)
Phase Changing Ultrasound Contrast Agents for Deep Tissue Imaging of Cellular Immunotherapies$619,228
R01 · FY2025 · CA · contact PI
Biomimetic Peptide Aerosols for Rapid Clearance of Pulmonary MDR Tuberculosis$448,864
R01 · FY2025 · AI · contact PI
Understanding and controlling the cellular fate of fluorine-modified biologics$381,376
R35 · FY2025 · GM · contact PI
Phase Changing Ultrasound Contrast Agents for Deep Tissue Imaging of Cellular Immunotherapies$490,381
R01 · FY2024 · CA · contact PI
Biomimetic Peptide Aerosols for Rapid Clearance of Pulmonary MDR Tuberculosis$478,139
R01 · FY2024 · AI · contact PI
Understanding and controlling the cellular fate of fluorine-modified biologics$381,515
R35 · FY2024 · GM · contact PI
Biomimetic Peptide Aerosols for Rapid Clearance of Pulmonary MDR Tuberculosis$394,630
R01 · FY2023 · AI · contact PI
Understanding and controlling the cellular fate of fluorine-modified biologics$381,654
R35 · FY2023 · GM · contact PI
Biomimetic Peptide Aerosols for Rapid Clearance of Pulmonary MDR Tuberculosis$396,522
R01 · FY2022 · AI · contact PI
Understanding and controlling the cellular fate of fluorine-modified biologics$392,240
R35 · FY2022 · GM · contact PI
Ultrasound-programmable gene editing in kidneys$201,090
R21 · FY2022 · DK · contact PI
Understanding and controlling the cellular fate of fluorine-modified biologics$407,000
R35 · FY2021 · GM · contact PI
Ultrasound-programmable gene editing in kidneys$178,122
R21 · FY2021 · DK · contact PI